FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Dec. 28, 2020 |
Oct. 01, 2022 |
Apr. 02, 2022 |
Oct. 01, 2022 |
Jul. 02, 2022 |
Oct. 02, 2021 |
|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | Ìý | Ìý | Ìý | Ìý | Ìý | Ìý |
| Impairment charge | Ìý | Ìý | Ìý | $ 229,044,000 | Ìý | Ìý |
| Long-term debt, carrying values | Ìý | $ 4,358,200,000 | $ 5,085,300,000 | 4,358,200,000 | Ìý | Ìý |
| Long-term debt, fair values | Ìý | 3,906,200,000 | 5,042,500,000 | 3,906,200,000 | Ìý | Ìý |
| Goodwill | Ìý | 2,102,700,000 | 2,393,807,000 | 2,102,700,000 | Ìý | $ 2,415,767,000 |
| Trademarks and trade names | Ìý | 2,683,152,000 | 2,896,648,000 | 2,683,152,000 | Ìý | Ìý |
| Supreme | Ìý | Ìý | Ìý | Ìý | Ìý | Ìý |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | Ìý | Ìý | Ìý | Ìý | Ìý | Ìý |
| Impairment charge | Ìý | 229,000,000 | 0 | Ìý | Ìý | Ìý |
| Impairment of indefinite lived intangible assets | Ìý | 192,900,000 | $ 0 | Ìý | Ìý | Ìý |
| Percent of fair value exceeding the carrying value | Ìý | Ìý | 5.00% | Ìý | Ìý | Ìý |
| Percent indefinite lived trademark intangible asset exceeding carrying value | Ìý | Ìý | 3.00% | Ìý | Ìý | Ìý |
| Goodwill | Ìý | 1,210,000,000 | Ìý | 1,210,000,000 | Ìý | Ìý |
| Trademarks and trade names | Ìý | $ 1,190,000,000 | Ìý | $ 1,190,000,000 | Ìý | Ìý |
| Supreme | Ìý | Ìý | Ìý | Ìý | Ìý | Ìý |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | Ìý | Ìý | Ìý | Ìý | Ìý | Ìý |
| Contingent consideration, earn out period | 1 year | Ìý | Ìý | Ìý | Ìý | Ìý |
| Contingent consideration arrangements, low value | Ìý | Ìý | Ìý | Ìý | $ 0 | Ìý |
| Contingent consideration arrangements, high value | Ìý | Ìý | Ìý | Ìý | $ 300,000,000 | Ìý |
| Contingent consideration | Ìý | Ìý | $ 57,000,000 | Ìý | Ìý | Ìý |
| X | ||||||||||
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of long-term debt and lease obligation, including portion classified as current. No definition available.
|
| X | ||||||||||
- Definition Business Combination, Contingent Consideration, Earn Out Period No definition available.
|
| X | ||||||||||
- Definition Percent Indefinite Lived Trademark Intangible Asset Exceeding Carrying Value No definition available.
|
| X | ||||||||||
- Definition Percent of Fair Value Exceeding Carrying Value No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|